Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng et al

• Pingfu Fu,
• Mohammadhadi Khorrami,
• Anant Madabhushi,
• Nathan Pennell,
• Khalid Jazieh,
• Vidya Sankar Viswanathan

Affiliations

Pingfu Fu

Population and Quantitattive Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA

Mohammadhadi Khorrami

Biomedical Engineering, Case Western Reserve Univ, Cleveland, Ohio, USA

Anant Madabhushi

Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA

Nathan Pennell

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA

Khalid Jazieh

Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA

Vidya Sankar Viswanathan

Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA